Rangering i aksjer
#15162
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development... Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Aksjekurs
$3.70
Sist synkronisert: 2026-08-28
Handel Hansa Biopharma AB (HNSBF)
Driftsmargin for Hansa Biopharma AB (HNSBF)
Driftsmargin per 2026 TTM: 0.00%
Ifølge Hansa Biopharma AB sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 0.00%. Ved slutten av 2026 hadde selskapet en driftsmargin på 0.00%.
Historikk for driftsmargin for Hansa Biopharma AB fra 2026 til 2026
Driftsmargin ved slutten av hvert år
| År |
Driftsmargin |
Endre |
|
Ikke nok data for de angitte datoene. |
Driftsmargin for lignende selskaper eller konkurrenter
| Selskap |
Driftsmargin |
Forskjell i driftsmargin |
Land |
|
|
62.34% |
-
|
US
|
|
|
0.00% |
-
|
SE
|
|
|
0.00% |
-
|
FR
|
|
|
0.00% |
-
|
IT
|
|
|
0.77% |
-
|
US
|
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.
